Metro Healthcare Berhad Announces Major Corporate Proposals: Free Warrants and Strategic Diversification of IPO Proceeds
Key Highlights of the Corporate Proposals
- Proposed Bonus Issue of Up to 244.7 Million Free Warrants: On the basis of 1 warrant for every 4 existing ordinary shares held by entitled shareholders.
- Proposed Variation in IPO Proceeds Utilisation: RM15.5 million (representing 65.7% of unutilised IPO proceeds) to be reallocated from the “expansion of existing O&G business” to “expansion of healthcare-related business.”
- Extraordinary General Meeting (EGM): Shareholders to vote on both proposals on 29 June 2026.
- Potential Fundraising: Assuming full exercise of warrants, up to RM48.9 million could be raised for future expansion and working capital.
- Strategic Shift: The group is moving towards a multi-disciplinary healthcare model, with plans including a new 120-bed specialist hospital in Bandar Rimbayu, Selangor.
Detailed Analysis for Investors
1. Proposed Bonus Issue of Warrants
Metro Healthcare Berhad is proposing to issue up to 244,726,250 free warrants to its shareholders, with an entitlement ratio of 1 warrant for every 4 existing shares held. The warrants will be issued at no cost to shareholders and are intended to reward existing shareholders, provide an alternative means of participation in the company’s equity, and serve as a potential fundraising mechanism in the future.
- Exercise Price: The exercise price will be set at a later date, at a discount not exceeding 20% to the five-day volume-weighted average price (VWAP) prior to price fixing. For illustration, an exercise price of RM0.20 per warrant (9.1% discount to recent VWAP) has been assumed, potentially raising up to RM48.9 million if all warrants are exercised.
- Tenure: The warrants will have a 5-year exercise period. Any unexercised warrants will lapse after expiry.
- Impact on Share Capital: If all warrants are exercised, the share base will increase from 978.9 million to 1,223.6 million shares. This could potentially dilute earnings per share (EPS), but also strengthen capital base and improve trading liquidity.
- Approvals: Bursa Malaysia has approved the proposals, subject to certain conditions. Final approval rests with shareholders at the upcoming EGM.
- Entitlement Date: To be announced after approval is obtained.
2. Proposed Variation in Utilisation of IPO Proceeds
In line with its new strategic direction, Metro Healthcare plans to redirect RM15.5 million of unutilised IPO proceeds (originally for O&G expansion) to broader healthcare-related businesses, including wellness, diagnostics, digital health, outpatient care, and multi-disciplinary specialist services.
- Material Change: This represents a 39.5% variation of total IPO proceeds, qualifying as a material change under Bursa’s rules and requiring shareholder approval.
- Use of Funds: The reallocated funds will be used, among others, to partially finance the construction and equipping of a 120-bed multi-disciplinary specialist hospital in Bandar Rimbayu, Selangor, via wholly-owned subsidiary RMC Specialist Sdn Bhd. Estimated construction and M&E costs for this allocation are RM15.5 million.
- Strategic Rationale: This move supports the group’s shift towards a diversified healthcare model, aiming to tap new revenue streams and reduce dependency on O&G specialty. It is also expected to reduce future bank borrowings and lower gearing.
Price-Sensitive and Shareholder-Relevant Issues
- Potential Dilution: The bonus issue, if fully exercised, will increase share base by 25%, diluting EPS unless earnings grow in tandem.
- Growth Prospects: The new hospital project and diversified service offerings could open up significant new revenue streams and market opportunities.
- Fundraising Without Immediate Dilution: Warrants offer a deferred equity fundraising alternative, with no immediate cash outflow or dilution until exercised. If the share price outperforms the exercise price, warrant conversion is likely, bringing in new capital.
- Execution Risks: The success of the new hospital and diversification initiatives are subject to market demand, regulatory approvals, and operational challenges, including securing qualified medical professionals.
- Industry Trends: The proposals come at a time of increased healthcare spending in Malaysia, government support for hospital infrastructure, and rising demand for private healthcare services and medical tourism.
Timeline and Next Steps
- EGM Date: 29 June 2026, 3:30 PM at Premiere Hotel, Klang.
- Shareholder Action: Shareholders are urged to vote at the EGM or appoint proxies. Proxy forms must be submitted by 27 June 2026, 3:30 PM.
- Expected Completion: Proposals are anticipated to be completed by Q3 2026, pending all approvals.
Directors’ Recommendation
The Board has unanimously recommended shareholders to vote in favour of both proposals, citing their alignment with the company’s growth strategy and long-term interests.
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Investors are advised to make their own independent assessment and seek professional guidance before making any investment decisions. The information provided is based on published documents as of 12 June 2026 and may be subject to change.
Versi Bahasa Malaysia
Metro Healthcare Berhad Umumkan Cadangan Korporat Utama: Waran Percuma & Penstrukturan Semula Penggunaan Hasil IPO
Sorotan Utama Cadangan Korporat
- Cadangan Terbitan Bonus sehingga 244.7 Juta Waran Percuma: Berdasarkan 1 waran bagi setiap 4 saham biasa sedia ada yang dipegang oleh pemegang saham yang layak.
- Cadangan Variasi Penggunaan Hasil IPO: RM15.5 juta (65.7% baki hasil IPO tidak digunakan) dialihkan daripada “pengembangan perniagaan O&G” kepada “pengembangan perniagaan berkaitan penjagaan kesihatan”.
- Mesyuarat Agung Luar Biasa (EGM): Pemegang saham akan mengundi kedua-dua cadangan pada 29 Jun 2026.
- Potensi Pengumpulan Dana: Jika semua waran dilaksanakan, sehingga RM48.9 juta boleh dikumpul untuk pengembangan masa depan dan modal kerja.
- Pergeseran Strategik: Syarikat beralih ke model penjagaan kesihatan pelbagai disiplin, termasuk hospital pakar 120 katil baharu di Bandar Rimbayu, Selangor.
Analisis Terperinci untuk Pelabur
1. Cadangan Terbitan Bonus Waran
Metro Healthcare Berhad mencadangkan penerbitan sehingga 244,726,250 waran percuma kepada pemegang saham, dengan nisbah 1 waran bagi setiap 4 saham sedia ada. Waran akan diterbitkan tanpa kos kepada pemegang saham dan bertujuan untuk memberi ganjaran, menyediakan kaedah penyertaan alternatif dalam ekuiti syarikat, dan sebagai mekanisme pengumpulan dana masa depan.
- Harga Pelaksanaan: Akan ditentukan kemudian, pada diskaun tidak melebihi 20% daripada VWAP lima hari sebelum penetapan harga. Sebagai ilustrasi, harga pelaksanaan RM0.20 setiap waran boleh mengumpul sehingga RM48.9 juta jika semua waran dilaksanakan.
- Tempoh: Waran mempunyai tempoh 5 tahun. Waran yang tidak dilaksanakan akan luput selepas tempoh ini.
- Kesan Ke Atas Modal Saham: Jika semua waran dilaksanakan, jumlah saham akan meningkat dari 978.9 juta kepada 1,223.6 juta, berpotensi mencairkan EPS kecuali keuntungan meningkat seiring.
- Kelulusan: Bursa Malaysia telah meluluskan cadangan, tertakluk kepada syarat tertentu. Kelulusan akhir terletak pada pemegang saham semasa EGM.
- Tarikh Kelayakan: Akan diumumkan selepas kelulusan diperoleh.
2. Cadangan Variasi Penggunaan Hasil IPO
Selaras dengan hala tuju strategik baharu, Metro Healthcare merancang mengalihkan RM15.5 juta hasil IPO yang tidak digunakan (asalnya untuk pengembangan O&G) kepada perniagaan penjagaan kesihatan yang lebih luas, termasuk wellness, diagnostik, kesihatan digital, rawatan pesakit luar, dan perkhidmatan pakar pelbagai disiplin.
- Perubahan Material: Ini mewakili 39.5% daripada jumlah hasil IPO, memenuhi syarat “material change” di bawah peraturan Bursa dan memerlukan kelulusan pemegang saham.
- Penggunaan Dana: Dana ini akan digunakan antaranya untuk membiayai sebahagian pembinaan dan penyediaan hospital pakar pelbagai disiplin 120 katil di Bandar Rimbayu menerusi anak syarikat milik penuh RMC Specialist Sdn Bhd.
- Rasional Strategik: Langkah ini menyokong peralihan syarikat ke arah model penjagaan kesihatan pelbagai disiplin, membuka aliran pendapatan baharu dan mengurangkan kebergantungan kepada kepakaran O&G. Ia juga dijangka mengurangkan pinjaman bank masa depan dan nisbah gearan.
Isu Sensitif Harga & Berkaitan Pemegang Saham
- Pencairan Potensi: Jika waran dilaksanakan sepenuhnya, jumlah saham meningkat 25%, mencairkan EPS kecuali keuntungan bertambah seiring.
- Prospek Pertumbuhan: Projek hospital baharu dan perkhidmatan pelbagai disiplin boleh membuka sumber pendapatan dan peluang pasaran baharu.
- Pengumpulan Dana Tanpa Pencairan Serta-merta: Waran menawarkan alternatif pengumpulan dana ekuiti secara tertunda, tanpa pencairan atau pengaliran tunai serta-merta sehingga dilaksanakan.
- Risiko Pelaksanaan: Kejayaan projek hospital dan inisiatif kepelbagaian bergantung kepada permintaan pasaran, kelulusan kawal selia dan cabaran operasi, termasuk mendapatkan kakitangan pakar.
- Trend Industri: Cadangan dibuat ketika perbelanjaan penjagaan kesihatan di Malaysia meningkat, disokong kerajaan, dan permintaan tinggi untuk perkhidmatan penjagaan kesihatan swasta dan pelancongan perubatan.
Garis Masa & Langkah Seterusnya
- Tarikh EGM: 29 Jun 2026, 3:30 PM di Premiere Hotel, Klang.
- Tindakan Pemegang Saham: Disaran hadir dan mengundi di EGM atau melantik proksi. Borang proksi mesti dihantar sebelum 27 Jun 2026, 3:30 PM.
- Jangkaan Siap: Cadangan dijangka siap pada S3 2026, tertakluk semua kelulusan diperolehi.
Rekomendasi Pengarah
Lembaga Pengarah sebulat suara mengesyorkan pemegang saham mengundi menyokong kedua-dua cadangan, sejajar dengan strategi pertumbuhan dan kepentingan jangka panjang syarikat.
Penafian
Artikel ini untuk tujuan makluman sahaja dan bukan nasihat pelaburan. Pelabur dinasihatkan melakukan penilaian sendiri dan mendapatkan nasihat profesional sebelum membuat sebarang keputusan pelaburan. Maklumat adalah berdasarkan dokumen yang diterbitkan pada 12 Jun 2026 dan tertakluk kepada perubahan.
